FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

A new study published in PNAS Nexus by researchers at Carnegie Mellon University (CMU) demonstrates how a noninvasive brain-computer interface (BCI) powered by artificial intelligence (AI) deep ...

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

In a remarkable leap forward for neuroscience and technological innovation, Elon Musk's brain implant company Neuralink has officially received approval from the FDA to begin the first human trials of ...

Brain-computer interface (BCI) technology creates a direct link between the brain’s electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, ...

The first human has received Neuralink’s brain-computer interface, which company founder Elon Musk has claimed could one day help the blind see, restore mobility to people with severe paralysis and ...

Many people with Lou Gehrig's disease, also called amyotrophic lateral sclerosis (ALS), first start to lose the ability to move their arms and legs. That's not Pat Bennett. She can move just fine. She ...

The Global Brain Computer Interface Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% from ...

Can technology read your mind? Divya Chander, M.D., Ph.D., has a surprising answer to that question. Chander is a neuroscientist and physician on the faculty at both Stanford University and ...